JP Morgan Chase’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$104M Buy
490,014
+46,498
+10% +$9.97M 0.01% 1052
2026
Q1
$97.3M Buy
443,516
+132,952
+43% +$32.5M 0.01% 1000
2025
Q4
$78.7M Sell
310,564
-355,539
-53% -$89.3M ﹤0.01% 1068
2025
Q3
$165M Sell
666,103
-7,843
-1% -$1.88M 0.01% 769
2025
Q2
$162M Sell
673,946
-368,481
-35% -$85.8M 0.01% 749
2025
Q1
$236M Buy
1,042,427
+58,729
+6% +$12.9M 0.02% 615
2024
Q4
$202M Sell
983,698
-32,498
-3% -$7.13M 0.02% 660
2024
Q3
$246M Sell
1,016,196
-2,776
-0.3% -$649K 0.02% 611
2024
Q2
$224M Sell
1,018,972
-48,772
-5% -$10.6M 0.02% 623
2024
Q1
$240M Buy
1,067,744
+156,077
+17% +$35.2M 0.02% 594
2023
Q4
$200M Buy
911,667
+356,183
+64% +$75.3M 0.02% 612
2023
Q3
$122M Buy
555,484
+51,229
+10% +$11.6M 0.01% 731
2023
Q2
$113M Buy
504,255
+7,273
+1% +$1.46M 0.01% 765
2023
Q1
$95.1M Buy
496,982
+53,618
+12% +$10.4M 0.01% 806
2022
Q4
$81.9M Sell
443,364
-32,975
-7% -$5.8M 0.01% 867
2022
Q3
$79.2M Sell
476,339
-72,618
-13% -$14.8M 0.01% 820
2022
Q2
$113M Sell
548,957
-27,431
-5% -$6.18M 0.02% 700
2022
Q1
$139M Buy
576,388
+225,775
+64% +$52.3M 0.02% 699
2021
Q4
$85.3M Buy
350,613
+231
+0.1% +$52.8K 0.01% 954
2021
Q3
$71.6M Sell
350,382
-1,074
-0.3% -$230K 0.01% 1019
2021
Q2
$72.5M Buy
351,456
+2,311
+0.7% +$465K 0.01% 1047
2021
Q1
$66.5M Buy
349,145
+3,343
+1% +$620K 0.01% 1049
2020
Q4
$65.5M Sell
345,802
-76,435
-18% -$14.3M 0.01% 961
2020
Q3
$73M Buy
422,237
+140,370
+50% +$22.4M 0.01% 814
2020
Q2
$43.3M Sell
281,867
-4,686
-2% -$714K 0.01% 955
2020
Q1
$40.1M Buy
286,553
+77,712
+37% +$11.6M 0.01% 898
2019
Q4
$31.8M Sell
208,841
-717,359
-77% -$105M 0.01% 1238
2019
Q3
$134M Buy
926,200
+133,638
+17% +$20M 0.03% 570
2019
Q2
$116M Buy
792,562
+493,578
+165% +$65.9M 0.02% 624
2019
Q1
$38.3M Buy
298,984
+70,332
+31% +$8.28M 0.01% 1103
2018
Q4
$24.4M Buy
228,652
+40,905
+22% +$4.57M 0.01% 1333
2018
Q3
$21.5M Sell
187,747
-58,065
-24% -$6.57M ﹤0.01% 1606
2018
Q2
$25.8M Buy
245,812
+20,231
+9% +$2.04M 0.01% 1395
2018
Q1
$21.1M Buy
225,581
+73,126
+48% +$6.65M ﹤0.01% 1468
2017
Q4
$13.3M Buy
152,455
+84,836
+125% +$7.57M ﹤0.01% 1896
2017
Q3
$5.93M Sell
67,619
-118,468
-64% -$10M ﹤0.01% 2427
2017
Q2
$15.2M Buy
186,087
+119,035
+178% +$9.05M ﹤0.01% 1646
2017
Q1
$4.66M Buy
67,052
+1,490
+2% +$103K ﹤0.01% 2485
2016
Q4
$4.42M Sell
65,562
-276,597
-81% -$18.8M ﹤0.01% 2555
2016
Q3
$25M Sell
342,159
-141,635
-29% -$10M 0.01% 1235
2016
Q2
$33.3M Sell
483,794
-132,708
-22% -$9.3M 0.01% 1045
2016
Q1
$43.8M Buy
616,502
+187,935
+44% +$12.7M 0.01% 883
2015
Q4
$32.3M Buy
428,567
+151,778
+55% +$11M 0.01% 1035
2015
Q3
$18M Buy
276,789
+73,524
+36% +$4.86M ﹤0.01% 1328
2015
Q2
$13.1M Buy
203,265
+93,732
+86% +$6.32M ﹤0.01% 1721
2015
Q1
$7.7M Buy
109,533
+77,176
+239% +$5.09M ﹤0.01% 2064
2014
Q4
$2.1M Buy
+32,357
New +$2M ﹤0.01% 2937
2014
Q1
Sell
-234,522
Closed -$11.3M 3904
2013
Q4
$11.3M Sell
234,522
-38,761
-14% -$1.77M ﹤0.01% 1705
2013
Q3
$11.7M Buy
273,283
+82,198
+43% +$3.57M ﹤0.01% 1667
2013
Q2
$8.19M Buy
+191,085
New +$8.22M ﹤0.01% 1800

Other funds holding STE

JP Morgan Chase's STE Position: Q2 2026 in Review

JP Morgan Chase increased its Steris (STE) stake by 10% in Q2 2026, buying an estimated $9.97M and bringing the position to 490,014 shares worth $104M. The position accounts for 0.01% of the portfolio, ranked #1052.

JP Morgan Chase first reported a position in STE in Q2 2013 and has held it in 50 quarters since. The position peaked at $246M in Q3 2024. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • JP Morgan Chase held 490,014 shares of Steris worth $104M as of Q2 2026.
  • JP Morgan Chase bought 46,498 Steris shares in Q2 2026, an estimated $9.97M.
  • Steris made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1052 holding.
  • JP Morgan Chase first reported a position in Steris in Q2 2013 and has held it in 50 quarters since.
  • JP Morgan Chase's Steris position peaked at $246M in Q3 2024.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.